Serum cystatin C and the incidence of type 2 diabetes mellitus

被引：0
|
作者：
K. Sahakyan
K. E. Lee
A. Shankar
R. Klein
机构：
[1] University of Wisconsin-Madison,Department of Ophthalmology and Visual Sciences
[2] West Virginia University School of Medicine,Department of Community Medicine
来源：
Diabetologia | 2011年 / 54卷
关键词：
Epidemiology; Pathogenic mechanisms; Prediction and prevention; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1335 / 1340
页数：5
相关论文
共 50 条
  • [1] Serum cystatin C and the incidence of type 2 diabetes mellitus
    Sahakyan, K.
    Lee, K. E.
    Shankar, A.
    Klein, R.
    [J]. DIABETOLOGIA, 2011, 54 (06) : 1335 - 1340
  • [2] Serum Cystatin C and the Incidence of Hypertension in Type 1 Diabetes Mellitus
    Sahakyan, Karine
    Klein, Barbara E. K.
    Lee, Kristine E.
    Tsai, Michael Y.
    Klein, Ronald
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2011, 24 (01) : 59 - 63
  • [3] The relationship between serum cystatin C and atherosclerosis in patients with type 2 diabetes mellitus
    Sohn, Tae Seo
    Lee, Jee In
    Lee, Seung Su
    Lee, Jung Min
    Chang, Sang Ah
    Moon, Sung Dae
    Han, Je Ho
    Yoo, Soon Jib
    Son, Hyun Shik
    Cha, Bong Yun
    [J]. DIABETES, 2008, 57 : A626 - A627
  • [4] Serum cystatin C as an endogenous marker of renal function in patients with diabetes mellitus type 2
    Zavrsnik, M
    Bevc, S
    Gorenjak, M
    Puklavec, L
    Hojs, R
    [J]. DIABETES, 2004, 53 : A208 - A208
  • [5] Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus
    Sapkota, Suman
    Khatiwada, Saroj
    Shrestha, Shrijana
    Baral, Nirmal
    Maskey, Robin
    Majhi, Shankar
    Chandra, Lal
    Lamsal, Madhab
    [J]. INTERNATIONAL JOURNAL OF NEPHROLOGY, 2021, 2021
  • [6] Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus
    Elsayed, Mohamed Shawky
    El Badawy, Ayman
    Ahmed, Abdelmon'em
    Omar, Rasha
    Mohamed, Amr
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 374 - 381
  • [7] Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with Type 2 diabetes mellitus
    Mojiminiyi, OA
    Abdella, N
    George, S
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2000, 60 (06): : 483 - 489
  • [8] Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
    Dejenie, Tadesse Asmamaw
    Abebe, Endeshaw Chekol
    Mengstie, Misganaw Asmamaw
    Seid, Mohammed Abdu
    Gebeyehu, Natnael Atnafu
    Adella, Getachew Asmare
    Kassie, Gizchew Ambaw
    Gebrekidan, Amanuel Yosef
    Gesese, Molalegn Mesele
    Tegegne, Kirubel Dagnaw
    Anley, Denekew Tenaw
    Feleke, Sefineh Fenta
    Zemene, Melkamu Aderajew
    Dessie, Anteneh Mengist
    Moges, Natnael
    Kebede, Yenealem Solomon
    Bantie, Berihun
    Adugna, Dagnew Getnet
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [9] APLICATION OF SERUM CYSTATIN C FOR PREDICTION OF NEPHROPATHY AND CARDIOVASCULAR DISEASES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Pasko, Nevi
    Strakosha, Ariana
    Toti, Florian
    Cadri, Vilma
    Mumajesi, Suela
    Dedej, Teuta
    Stefa, Enkeleda
    Barbullushi, Myftar
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 614 - 614
  • [10] Association between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus without Nephropathy
    Kim, Hye Jeong
    Byun, Dong Won
    Suh, Kyoil
    Yoo, Myung Hi
    Park, Hyeong Kyu
    [J]. DIABETES & METABOLISM JOURNAL, 2018, 42 (06) : 513 - 518
12345